Multi-cancer blood tests promise early detection, but the evidence is thin, the risks real, and they’re no substitute for listening to your body.

Channel 4 has revealed that Stand Up To Cancer 2025 prompted meaningful attitudinal shifts among viewers, according to a ...

A former Love Island contestant has become the first man to speak out about how a cancer-linked pregnancy drug taken by his grandmother in the 1970s has impacted his own health. Maxwell Samuda has a ...

AI in advertising has gone from a buzzword to a full disruptor in what feels like just a few months. If CES was any indication, there is no sign of this slowing down. Yet, although everyone’s talking, ...

Researchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four cancers. The enzyme, N4BP2, breaks apart DNA trapped in tiny cellular ...

Fox will air a rerun of “The Real Full Monty” in James Van Der Beek’s honor Wednesday. The encore of the 2024 two-hour special, which set out to raise awareness for prostate, testicular and colorectal ...

One of James Van Der Beek's final projects is returning to the small screen. Fox announced that as a tribute to the late Dawson's Creek star, the network will re-air The Real Full Monty, a cancer ...

Objectives To investigate associations between daily physical activity, activity intensity and step counts with incident cancer risk. Methods Prospective analysis of UK Biobank participants who wore ...

In a world where everything from baby formula to cleaning products gets a wellness autopsy, sunscreen inevitably gets dragged onto the table. Then, when unqualified influencers promote conflicting ...

A real-world comparison of two androgen receptor pathway inhibitors (ARPIs) for advanced prostate cancer showed a significant difference in overall survival (OS). Patients with metastatic ...

"You can't have a cut of that scale and not expect to see a massive impact." When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Breaking space news, ...

Erleada significantly reduces the risk of death by 51% in mCSPC patients compared to Nubeqa, without chemotherapy, over 24 months. The study used inverse probability of treatment weighting to ensure ...